• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗磷脂综合征与类风湿关节炎的合并症患病率相当或更高:一项多中心病例对照研究。

Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.

机构信息

Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens.

Medical School, University of Thessaly, Larissa.

出版信息

Rheumatology (Oxford). 2021 Jan 5;60(1):170-178. doi: 10.1093/rheumatology/keaa321.

DOI:10.1093/rheumatology/keaa321
PMID:32596727
Abstract

OBJECTIVES

Evidence on comorbidity prevalence in antiphospholipid syndrome (APS) and its difference from high comorbidity burden rheumatic diseases is limited. Herein, we compare multiple comorbidities between APS and RA.

METHODS

A total of 326 patients from the Greek APS registry [237 women, mean age 48.7 (13.4) years, 161 primary APS (PAPS), 165 SLE-APS] were age/sex matched (1:2 ratio) with 652 patients from a Greek multicentre RA cohort of 3115 patients. Prevalence of cardiovascular (CV) risk factors, stroke, coronary artery disease (CAD), osteoporosis, diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), depression and neoplasms were compared between APS and RA patients using multivariate regression analysis.

RESULTS

Ηyperlipidemia and obesity (ΒΜΙ ≥ 30 kg/m2) were comparable while hypertension, smoking, stroke and CAD were more prevalent in APS compared with RA patients. Osteoporosis and depression were more frequent in APS, while DM, COPD and neoplasms did not differ between the two groups. Comparison of APS subgroups to 1:2 matched RA patients revealed that smoking and stroke were more prevalent in both PAPS and SLE-APS vs RA. Hypertension, CAD and osteoporosis were more frequent only in SLE-APS vs RA, whereas DM was less prevalent in PAPS vs RA. Hyperlipidaemia was independently associated with CV events (combined stroke and CAD) in PAPS and SLE-APS, while CS duration was associated with osteoporosis in SLE-APS.

CONCLUSION

Comorbidity burden in APS (PAPS and SLE-APS) is comparable or higher than that in RA, entailing a high level of diligence for CV risk prevention, awareness for depression and CS exposure minimization.

摘要

目的

抗磷脂综合征(APS)的合并症患病率及其与高合并症负担的风湿性疾病的差异的证据有限。在此,我们比较了 APS 和类风湿关节炎(RA)之间的多种合并症。

方法

共有 326 名来自希腊 APS 登记处的患者(237 名女性,平均年龄 48.7±13.4 岁,161 名原发性 APS(PAPS),165 名 SLE-APS),与来自希腊多中心 RA 队列的 3115 名患者中的 652 名患者进行年龄/性别匹配(1:2 比例)。使用多变量回归分析比较 APS 和 RA 患者之间心血管(CV)危险因素、中风、冠心病(CAD)、骨质疏松症、糖尿病(DM)、慢性阻塞性肺疾病(COPD)、抑郁症和肿瘤的患病率。

结果

高脂血症和肥胖(BMI≥30kg/m2)相似,而高血压、吸烟、中风和 CAD 在 APS 患者中比 RA 患者更常见。骨质疏松症和抑郁症在 APS 中更为常见,而 DM、COPD 和肿瘤在两组之间无差异。与 1:2 匹配的 RA 患者比较 APS 亚组发现,无论是 PAPS 还是 SLE-APS,吸烟和中风的发生率均高于 RA。高血压、CAD 和骨质疏松症仅在 SLE-APS 中比 RA 更常见,而 PAPS 中 DM 的发生率低于 RA。高脂血症与 PAPS 和 SLE-APS 的 CV 事件(中风和 CAD 合并)独立相关,而 CS 持续时间与 SLE-APS 的骨质疏松症相关。

结论

APS(PAPS 和 SLE-APS)的合并症负担与 RA 相当或更高,需要高度警惕预防 CV 风险、注意抑郁症和尽量减少 CS 暴露。

相似文献

1
Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.抗磷脂综合征与类风湿关节炎的合并症患病率相当或更高:一项多中心病例对照研究。
Rheumatology (Oxford). 2021 Jan 5;60(1):170-178. doi: 10.1093/rheumatology/keaa321.
2
Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.系统性硬化症与类风湿关节炎合并症患病率的比较:一项多中心、匹配队列研究。
Arthritis Res Ther. 2018 Dec 4;20(1):267. doi: 10.1186/s13075-018-1771-0.
3
Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus.抗磷脂综合征的心血管风险管理:随时间的变化趋势及与类风湿关节炎和糖尿病的比较。
Lupus Sci Med. 2021 Dec;8(1). doi: 10.1136/lupus-2021-000579.
4
Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus.与类风湿关节炎和糖尿病相比,银屑病关节炎患者的抑郁症发病率更高,心血管合并症情况相似。
Ther Adv Musculoskelet Dis. 2020 Dec 8;12:1759720X20976975. doi: 10.1177/1759720X20976975. eCollection 2020.
5
Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.抗磷脂综合征、类风湿关节炎和糖尿病患者的代谢综合征:与动脉血栓形成、心血管风险生物标志物、身体活动和冠状动脉粥样硬化斑块的关系。
Front Immunol. 2023 Jan 9;13:1077166. doi: 10.3389/fimmu.2022.1077166. eCollection 2022.
6
[Occurrence of cardiovascular events within a large population of patients affected by rheumatoid arthritis with or without diabetes.].[类风湿关节炎患者(伴或不伴糖尿病)大群体中心血管事件的发生情况。]
Recenti Prog Med. 2023 Feb;114(2):94-109. doi: 10.1701/3966.39449.
7
Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.抗磷脂综合征患者的颈动脉和股动脉粥样硬化:病例对照研究中与糖尿病相当的风险。
Semin Arthritis Rheum. 2018 Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015. Epub 2017 Oct 23.
8
Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.抗磷脂综合征损伤指数 (DIAPS):原发性抗磷脂综合征和与系统性红斑狼疮相关的抗磷脂综合征的明显长期动力学差异。
Lupus. 2020 Mar;29(3):256-262. doi: 10.1177/0961203320901598. Epub 2020 Jan 27.
9
Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke?抗磷脂综合征合并风湿热:中风的更高风险因素?
Rheumatol Int. 2012 Jun;32(6):1721-5. doi: 10.1007/s00296-011-1875-1. Epub 2011 Mar 25.
10
Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.患有难治性类风湿关节炎患者的合并症负担和临床特征。
Clin Rheumatol. 2019 Sep;38(9):2473-2481. doi: 10.1007/s10067-019-04579-1. Epub 2019 May 10.

引用本文的文献

1
Epidemiology and factors associated with osteoporosis, falls and fractures in patients with chronic inflammatory rheumatic disease: a scoping review.慢性炎症性风湿性疾病患者骨质疏松症、跌倒和骨折的流行病学及相关因素:一项范围综述
BMJ Open. 2025 Jul 28;15(7):e096226. doi: 10.1136/bmjopen-2024-096226.
2
Risk factors for cerebral infarction and cerebrovascular stenosis in antiphospholipid antibody-positive patients: A retrospective single-center study with propensity score matching analysis.抗磷脂抗体阳性患者脑梗死和脑血管狭窄的危险因素:回顾性单中心研究与倾向评分匹配分析。
Medicine (Baltimore). 2024 Sep 27;103(39):e39890. doi: 10.1097/MD.0000000000039890.
3
Chronic rheumatologic disorders and cardiovascular disease risk in women.
女性慢性风湿性疾病与心血管疾病风险
Am Heart J Plus. 2023 Feb 9;27:100267. doi: 10.1016/j.ahjo.2023.100267. eCollection 2023 Mar.
4
Seven-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls.抗磷脂综合征患者与糖尿病患者及健康对照者的七年随访期动脉粥样硬化斑块进展情况
Rheumatology (Oxford). 2025 Feb 1;64(2):836-841. doi: 10.1093/rheumatology/keae097.
5
Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.抗磷脂综合征的流行病学:大血管和微血管表现。
Rheumatology (Oxford). 2024 Feb 6;63(SI):SI24-SI36. doi: 10.1093/rheumatology/kead571.
6
Non-pharmacological rehabilitation interventions for individuals with antiphospholipid syndrome: A scoping review.抗磷脂综合征患者的非药物康复干预措施:范围综述。
Lupus. 2024 Feb;33(2):101-110. doi: 10.1177/09612033231223336. Epub 2023 Dec 19.
7
Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools.抗磷脂综合征患者的心血管风险评估:九种临床风险预测工具的横断面性能分析。
RMD Open. 2023 Nov 27;9(4):e003601. doi: 10.1136/rmdopen-2023-003601.
8
Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome.欧洲抗风湿病联盟和欧洲心脏病学会关于抗磷脂综合征血压和血脂管理的建议的应用。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003326.
9
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.抗磷脂抗体阳性患者的抗磷脂综合征损伤指数(DIAPS)测量结果,这些患者均纳入 APS ACTION 注册研究。
Rheumatology (Oxford). 2024 Mar 1;63(3):772-779. doi: 10.1093/rheumatology/kead292.
10
Arterial stiffness tested by pulse wave velocity and augmentation index for cardiovascular risk stratification in antiphospholipid syndrome.采用脉搏波速度和增强指数检测动脉僵硬度在抗磷脂综合征心血管风险分层中的应用。
Rheumatology (Oxford). 2024 Apr 2;63(4):1030-1038. doi: 10.1093/rheumatology/kead267.